prostate cancer

GSK pens $357M pact with French biotech for prostate cancer ADC

Fresh from a European cancer conference that was all about ADCs, GSK has turned to French biotech Syndivia for a preclinical prostate cancer prospect.

James Waldron Oct 27, 2025 4:07am

Alpenglow teams up with Virdx to boost prostate cancer diagnosis

Oct 8, 2025 9:20am

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Sep 24, 2025 11:30am

A series of dice with a bag on them illustrating cost cuts

Oric lays off 20% of workforce in focus on clinical-stage drugs

Aug 13, 2025 6:20am

Paint brushes sitting on a colorful canvas

Radiopharma biotech Artbio paints path to clinic with $132M

Jul 29, 2025 7:30am

MA strategy deal block push come together form

Research non-profit acquires embattled Essa in Xoma-backed deal

Jul 14, 2025 9:30am